Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium Citrate ER for Urolithiasis Recurrence
NCT03007160Phase 4Unknown
- Sponsor
- Dawnrays Pharmaceutical (Holdings) Limited
- Start
- Jul 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of potassium citrate in urolithiasis, sponsored by Dawnrays Pharmaceutical (Holdings) Limited. Status: unknown.
02
Drugs
potassium citrate
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT03007160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007160.